Other Clinical Trial - IW-6463 Safety Study in Healthy Elderly Subjects

Status Terminated

Clinical Trial Summary

This is a randomized, double-blind, placebo-controlled, 2-way cross-over study in healthy male and female elderly participants.

Clinical Trial Description

Participants will receive up to a total of 30 daily doses of study drug (15 days of daily IW-6463, only; 15 days of daily placebo, only) administered across two 15-day dosing periods (Period 1 and Period 2). The dosing periods will be separated by a 27-day washout. Participants will be randomized to a sequence of receiving IW-6463 for Period 1 and then placebo for Period 2, or vice versa. ;

Study Design

Related Conditions & MeSH terms

Other

Clinical Trial Details

NCT number	NCT04240158
Study type	Interventional
Source	Tisento Therapeutics
Contact
Status	Terminated
Phase	Phase 1
Start date	January 6, 2020
Completion date	May 22, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03489187` - Visualase Visualization Database (VIVID-1)
Completed	`NCT06312449` - Effect of Peanut Balls Used of the Second Stage of Labor, Pushing Perceptions, Fatigue and Birth Outcomes	N/A
Completed	`NCT03775694` - Diffusion MRI-1 Imaging Database
Recruiting	`NCT00840047` - Methionine PET/CT Studies In Patients With Cancer	Phase 2
Completed	`NCT04236921` - Bioequivalence Bewteen DopaSnap® (Cabidopa/Levopdoap 25/100 mg Tablet) and Carbidopa/Levodopa 25/100 mg Tablet (Actavis)	Phase 1
Recruiting	`NCT06336980` - Creating Welcoming Faith Communities for People With Serious Mental Illnesses	N/A
Completed	`NCT03856827` - A Study of IW-6463 in Healthy Volunteers	Phase 1
No longer available	`NCT03723083` - Expanded Access for CC-2001